# Ametek Inc/: overview

AME · NYSE · CIK 1037868 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ame.md) · [Financials](/companies/ame/financials.md) · [Filings](/companies/ame/filings.md) · [Insiders](/companies/ame/insiders.md)

Latest reported revenue: [$2.04bn](/filings/0001037868-26-000175.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001037868-26-000175).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,709](/filings/0001037868-25-000077.md) | [1,762 d](/filings/0001037868-26-000016.md) | [1,732](/filings/0001037868-26-000144.md) | [1,778](/filings/0001037868-26-000175.md) | [1,893](/filings/0001037868-25-000077.md) | [1,998 d](/filings/0001037868-26-000016.md) | [1,928](/filings/0001037868-26-000144.md) | [2,044](/filings/0001037868-26-000175.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [26.1%](/filings/0001037868-25-000077.md) | [26.6% d](/filings/0001037868-26-000016.md) | [26.3%](/filings/0001037868-26-000144.md) | [26.0%](/filings/0001037868-26-000175.md) | [25.8%](/filings/0001037868-25-000077.md) | [25.3% d](/filings/0001037868-26-000016.md) | [26.7%](/filings/0001037868-26-000144.md) | [25.8%](/filings/0001037868-26-000175.md) |
| Net margin | % | [19.9%](/filings/0001037868-25-000077.md) | [22.0% d](/filings/0001037868-26-000016.md) | [20.3%](/filings/0001037868-26-000144.md) | [20.2%](/filings/0001037868-26-000175.md) | [19.6%](/filings/0001037868-25-000077.md) | [19.9% d](/filings/0001037868-26-000016.md) | [20.7%](/filings/0001037868-26-000144.md) | [19.9%](/filings/0001037868-26-000175.md) |
| Diluted EPS | $ per share | [1.47](/filings/0001037868-25-000077.md) | not reported | [1.52](/filings/0001037868-26-000144.md) | [1.55](/filings/0001037868-26-000175.md) | [1.60](/filings/0001037868-25-000077.md) | not reported | [1.74](/filings/0001037868-26-000144.md) | [1.77](/filings/0001037868-26-000175.md) |
| Free cash flow | $m | [461 d](/filings/0001037868-25-000077.md) | [498 d](/filings/0001037868-26-000016.md) | [394](/filings/0001037868-26-000144.md) | [330 d](/filings/0001037868-26-000175.md) | [420 d](/filings/0001037868-25-000077.md) | [527 d](/filings/0001037868-26-000016.md) | [426](/filings/0001037868-26-000144.md) | [452 d](/filings/0001037868-26-000175.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,547](/filings/0001037868-24-000009.md) | [6,151](/filings/0001037868-25-000012.md) | [6,597](/filings/0001037868-26-000016.md) | [6,941](/filings/0001037868-26-000016.md) | [7,401](/filings/0001037868-26-000016.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [23.6%](/filings/0001037868-24-000009.md) | [24.4%](/filings/0001037868-25-000012.md) | [25.9%](/filings/0001037868-26-000016.md) | [25.6%](/filings/0001037868-26-000016.md) | [25.8%](/filings/0001037868-26-000016.md) |
| Net margin | % | [17.9%](/filings/0001037868-24-000009.md) | [18.9%](/filings/0001037868-25-000012.md) | [19.9%](/filings/0001037868-26-000016.md) | [19.8%](/filings/0001037868-26-000016.md) | [20.0%](/filings/0001037868-26-000016.md) |
| Diluted EPS | $ per share | [4.25](/filings/0001037868-24-000009.md) | [5.01](/filings/0001037868-25-000012.md) | [5.67](/filings/0001037868-26-000016.md) | [5.93](/filings/0001037868-26-000016.md) | [6.40](/filings/0001037868-26-000016.md) |
| Free cash flow | $m | [1,050](/filings/0001037868-24-000009.md) | [1,010](/filings/0001037868-25-000012.md) | [1,599](/filings/0001037868-26-000016.md) | [1,702](/filings/0001037868-26-000016.md) | [1,672](/filings/0001037868-26-000016.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ame/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $4.73bn | 19,533,471 |  | Added +705,214 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $3.62bn | 14,978,776 |  | Added +52,261 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $2.50bn | 10,342,632 |  | Added +258,747 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $2.41bn | 9,952,184 |  | Added +101,326 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $1.48bn | 6,143,082 |  | Added +17,769 |
| [NORGES BANK](/funds/1374170.md) | 2026-06-30 | $1.04bn | 4,303,368 |  | New +4,303,368 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $1.04bn | 4,371,879 |  | Reduced −285,520 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $1.03bn | 4,277,408 |  | Reduced −80,845 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $906.3m | 3,745,827 |  | Reduced −122,525 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $724.4m | 2,994,077 |  | Added +196,986 |

## Recent filings

[All 1,762 filings](/companies/ame/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-26 | 16:42 ET | [8-K](/filings/0001037868-26-000191.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001037868-26-000191 |
| 2026-08-11 | 14:00 ET | [8-K](/filings/0001037868-26-000183.md) | 8.01 Other events | 0001037868-26-000183 |
| 2026-08-04 | 14:40 ET | [10-Q](/filings/0001037868-26-000175.md) | Quarterly report, period 2026-06-30 | 0001037868-26-000175 |
| 2026-08-04 | 09:56 ET | [8-K](/filings/0001037868-26-000173.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001037868-26-000173 |
| 2026-06-12 | 14:58 ET | [8-K](/filings/0001037868-26-000166.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001037868-26-000166 |
| 2026-05-26 | 13:38 ET | [8-K](/filings/0001037868-26-000163.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001037868-26-000163 |
| 2026-05-11 | 10:11 ET | [8-K](/filings/0001037868-26-000157.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001037868-26-000157 |
| 2026-05-08 | 10:49 ET | [8-K](/filings/0001037868-26-000151.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001037868-26-000151 |
| 2026-05-06 | 14:32 ET | [8-K](/filings/0001037868-26-000146.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001037868-26-000146 |
| 2026-04-30 | 14:28 ET | [10-Q](/filings/0001037868-26-000144.md) | Quarterly report, period 2026-03-31 | 0001037868-26-000144 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001037868-26-000016.md), filed Feb 17, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/991c6a8b-fff4-4cb8-9ee8-8b47962a4dc3)

## About the filer

- CIK: 1037868
- Tickers: AME
- Exchange: NYSE
- SIC code: 3823 Industrial Instruments For Measurement, Display, and Control
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.